Related references
Note: Only part of the references are listed.Increased Reporting of Detectable Plasma HIV-1 RNA Levels at the Criticial Threshold of 50 Copies per Milliliter With the Taqman Assay in Comparison to the Amplicor Assay
Viviane Lima et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48
Roberto Ortiz et al.
AIDS (2008)
Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: A systematic review of clinical trials
Ravindra Gupta et al.
CLINICAL INFECTIOUS DISEASES (2008)
Genotypic antiretroviral drug resistance testing at low viral loads in the UK
P. A. Cane et al.
HIV MEDICINE (2008)
British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008
B. G. Gazzard
HIV MEDICINE (2008)
Antiretroviral treatment of adult HIV infection - 2008 recommendations of the International AIDS Society USA panel
Scott M. Hammer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Episodes of low-level viral rebound in HIV-infected patients on antiretroviral therapy:: frequency, predictors and outcome
Pilar Garcia-Gasco et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Class-sparing regimens for initial treatment of HIV-1 infection
Sharon A. Riddler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assays
F. Damond et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Emergence of HIV-1 drug resistance in previously untreated patients initiating combination Antiretroviral treatment -: A comparison of different regimen types
Viktor Von Wyl et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes
Marie Gueudin et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2007)
ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia
Frank Maldarelli et al.
PLOS PATHOGENS (2007)
The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacovir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial (vol 368, pg 476, 2006)
Joseph Eron et al.
LANCET (2006)
Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV
JE Gallant et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Duration of an intermittent episode of viremia
M Di Mascio et al.
BULLETIN OF MATHEMATICAL BIOLOGY (2005)
Abacavir once or twice daily combined with once-daily lamivudine and efavirenz for the treatment of antiretroviral-naive HIV-infected adults - Results of the ziagen once doily in antiretrovirol combinotion study
GJ Moyle et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2005)
Intermittent HIV-1 viremia (blips) and drug resistance in patients receiving HAART
RE Nettles et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia
AC Karlsson et al.
AIDS (2004)
Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection
RM Gulick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Abacavir versus zidovudine combined with lamivudine and efavirenz, for the treatment of antiretroviral-naive HIV-infected adults
E DeJesus et al.
CLINICAL INFECTIOUS DISEASES (2004)
Once-daily versus twice-daily lamivudine, in combination with zidovudine and efavirenz, for the treatment of antiretroviral-naive adults with HIV infection: A randomized equivalence trial
E DeJesus et al.
CLINICAL INFECTIOUS DISEASES (2004)
SOLO:: 48-week efficacy and safety comparison of once-daily fosamprenavir/ritonavir versus twice-daily nelfinavir in naive HIV-1-infected patients
JC Gathe et al.
AIDS (2004)
The distribution of viral blips observed in HIV-1 infected patients treated with combination antiretroviral therapy
JK Percus et al.
BULLETIN OF MATHEMATICAL BIOLOGY (2003)
Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy
G Greub et al.
AIDS (2002)
Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection
S Walmsley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Prevalence and predictive value of intermittent viremia with combination HIV therapy
DV Havlir et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
